Pilihan Pengobatan Dermatologis Penuaan Periorbital
DOI:
https://doi.org/10.55175/cdk.v47i10.547Kata Kunci:
Penuaan periorbital, terapiAbstrak
Penuaan periorbital merupakan suatu proses tanpa henti dan tak terhindarkan seiring waktu. Meskipun tidak membahayakan fisik, kondisi ini memiliki berbagai efek psikososial dan fungsional. Tanda-tanda penuaan periorbital meliputi pembentukan kantung kelopak mata, kerutan periorbital, dan hiperpigmentasi kelopak mata. Penyebab utama serta faktor kontribusinya harus diidentifikasi dan diobati. Pilihan pengobatan antara lain agen topikal (hidrokuinon, asam kojic, asam azelaic, asam retinoat topikal), dan terapi fisik (chemical peel, terapi laser, transplantasi lemak autolog, injeksi fillers, plasma kaya platelet, dan injeksi botulinum toxins), sebagian besar telah teruji secara ilmiah.
Periorbital aging is an endless and inevitable process. Although this condition does not cause physical harm, it has various psychosocial and functional effects. Signs of periorbital aging include eyelid pouch formation, periorbital wrinkles, and eyelid hyperpigmentation. The goal of treatment is to identify and treat the main causes and their contributing factors. Available treatment options are topical agents (hydroquinone, kojic acid, azelaic acid, topical retinoic acid), and physical therapy (chemical peels, laser therapy, autologous fat transplants, fillers injection, platelet rich plasma, and injection of Botulinum toxins), most have been scientifically tested.
Unduhan
Referensi
Oliveira TCF, Rocha SFS, Ramos DG, Ramos CG, Carvalho MVA, Ramos MG. Effects of multipolar radiofrequency and pulsed electromagnetic field treatment for face and neck rejuvenation. Dermatol Res Practice, 2017;2017:4146391.
Vrcek I, Ozgur O, Nakra T. Infraorbital dark circles: A review of the pathogenesis, evaluation and treatment. J Cutan Aesthet Surg, 2016;9:65-72.
Chuang AYC, Liao SL. Periorbital rejuvenation surgery in the geriatric population. Internat J Gerontol. 2010;4(3):107-14.
Ranneva E, Siquier G, Liplavk O. New medical approach for rejuvenation of the periorbital area. Clin Med Invest. 2016;1(1):27-30.
Parsa AA, Lye KD, Radcliffe N, Parsa FD. Lower blepharoplasty with capsulopalpebral fascia hernia repair for palpebral bags: A long-term prospective study. Plast Reconstr Surg. 2008;121:1387–97.
Bassichis BA. Lower lid blepharoplasty. Operative Techniques in Otolaryngology-Head and Neck Surg. 2007;18(3):209-16.
Troell RJ. Peri-orbital aesthetic rejuvenation surgical protocol and clinical outcomes. Am J Cosmetic Surg. 2017;34(2):81–91.
Frueh BR, Musch DC, McDonald HM. Efficacy and efficiency of a small-incision, minimal dissection procedure versus a traditional approach for correcting aponeurotic ptosis. Ophthalmology 2004;111:2158–63.
Sarkar R, Ranjan R, Garg S, Garg VK, Sonthalia S, Bansal S. Periorbital hyperpigmentation: A comprehensive review. J Clin Aesthet Dermatol. 2016;9(1):49-55.
Taskin B. Periocular pigmentation: Overcoming the difficulties. J Pigmentary Disorders 2015;2(1):1-3.
Boruah D, Manu V, Malik A, Chatterjee M, Vasudevan B, Srinivas V. Morphometric study of melanocytes in periorbital hyperpigmentation. Indian J Dermatol Venereol Leprology 2015;81(6):588-93.
Roh MR, Chung KY. Infraorbital dark circles: Definition, causes, and treatment options. Dermatol Surg. 2009;35:1163–71.
Ranu H, Thng S, Goh BK, Burger A, Goh CL. Periorbital hyperpigmentation in Asians: An epidemiologic study and a proposed classification. Dermatol Surg. 2011;37(9):1297–1303.
Ranjan R, Sarkar R, Garg VK, Gupta T. Periorbital hyperpigmentation: Hydroquinone versus salicylic acid. Indian J Dermatol. 2016;61(4):413-7.
Ertam I, Mutlu B, Unal I, Alper S, Kivcak B, Ozer O. Efficiency of ellagic acid and arbutin in melasma: A randomized, prospective, open-label study. J Dermatol. 2008;35(9):570–4.
Ohshima H, Mizukoshi K, Oyobikawa M, Matsumoto K, Takiwaki H, Kanto H, et al. Effects of vitamin C on dark circles of the lower eyelids: quantitative evaluation using image analysis and echogram. Skin Res Technol. 2009;15(2):214.
Vavouli C, Katsambas A, Gregoriou S, Teodor A, Salavastru C, Alexandru A, et al. Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles. J Cosmet Dermatol. 2013;12:204-9.
Sheth, et al. Periorbital hyperpigmentation: Epidemiological study. Indian J 2014;59(2):151-7.
Momosawa A, Kurita M, Ozaki M, Miyamoto S, Kobayashi Y, Ban I, et al. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians. Plast Reconstr Surg 2008;121:282-8.
Alster T, Bellew SG. Improvement of dermatochalasis and periorbital rhytides with a high‐energy pulsed CO2 laser: A retrospective study. Dermatologic Surgery. 2004;30(4 Pt 1):483-7.
Chia CY, Rovaris DA. Autologous periorbital fat grafting in facial rejuvenation: A retrospective analysis of efficacy and safety in 31 cases. Rev Bras Cir Plást. 2012;27(3):405-10.
Bosniak S, Sadick NS, Cantisano Zilkha M, Glavas IP, Roy D. The hyaluronic acid push technique for the nasojugal groove. Dermatol Surg. 2008;34(1):127–31.
Freitag FM, Cestari TF. Dark circles. J Cosmetic Dermatol. 2007;6:211-5
El Safoury OS, El Fatah DSA, Ibrahim M. Treatment of periocular hyperpigmentation. Indian J Dermatol. 2009:54(4):361-3.
Souza DM, et al. Periorbital hyperchromia. Surg Cosmet Dermatol 2011;3(3):233-9.
Carruthers A, Kane MAC, Flynn TC, Huang P, Kim SD, Solish N, et al. The convergence of medicine and neurotoxins: A focus on botulinum toxin type A and its application in aesthetic medicine-a global, evidence-based botulinum toxin consensus education initiative: part I: Botulinum toxin in clinical and cosmetic practice. Dermatol Surg, 2013;39(3 Pt 2):493-509.
Carruthers J, Fournier N, Kerscher M, Ruiz-Avila J, Trindade de Almeida AR, Kaeuper G. The convergence of medicine and neurotoxins: A focus on botulinum toxin type A and its application in aesthetic medicine-a global, evidence-based botulinum toxin consensus education initiative: part II: botulinum toxin in clinical and cosmetic practice. Dermatol Surg, 2013;39(3 Pt 2):510-25.
Beer KR, Bayers S, Beer J. Aesthetic treatment considerations for the eyebrows and periorbital complex. J Drug Dermatol. 2014;13(1):17-20.
Flynn TC, Carruthers JA, Carruthers JA, Clark RE 2nd. Botulinum A toxin (BOTOX) in the lower eyelid: Dose-finding study. Dermatol Surg. 2003;29(9):943-51.
Yamauchi PS, Lask GP, Lowe NJ. Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing. Cosmet Laser Ther. 2004;6:145–8
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2020 https://creativecommons.org/licenses/by-nc/4.0/
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
